Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-20T02:36:52.427Z Has data issue: false hasContentIssue false
  • English
  • Français

Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose

Published online by Cambridge University Press:  19 October 2009

F. M. Rodrigues ,
V. B. Mandke ,
M. Roumiantzeff ,
C. V. R. Mohan Rao ,
J. M. Mehta ,
K. M. Pavri  and
C. Poonawalla
F. M. Rodrigues
Affiliation:
National Institute of Virology, 20-A Dr. B. R. Ambedkar Road, Pune 411 001, India;
V. B. Mandke
Affiliation:
National Institute of Virology, 20-A Dr. B. R. Ambedkar Road, Pune 411 001, India;
M. Roumiantzeff
Affiliation:
Institut Merieux, 58 Avenue Leclerc, Lyon, France
C. V. R. Mohan Rao
Affiliation:
National Institute of Virology, 20-A Dr. B. R. Ambedkar Road, Pune 411 001, India;
J. M. Mehta
Affiliation:
Serum Institute of India Research Foundation, Hadapsar, Pune 411 028, India
K. M. Pavri
Affiliation:
National Institute of Virology, 20-A Dr. B. R. Ambedkar Road, Pune 411 001, India;
C. Poonawalla
Affiliation:
Serum Institute of India Research Foundation, Hadapsar, Pune 411 028, India
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

In 1978, 22 staff members of the National Institute of Virology, Pune, India, were given two doses of human diploid cell antirabies vaccine (HDCV) for primary pre-exposure prophylactic immunization; the interval between the two doses being approximately 4 weeks. Eighteen of these 22 vaccinees were given a booster dose 1 year later. All 18 vaccinees developed protective levels of antibody; most of them had antibody levels exceeding 10 IU/ml.

In 1984, 5 years after the booster dose, 11 (79·0%) of 14 vaccinees tested still possessed neutralizing antibody levels ranging from 0·5 IU/ml to 10 IU/ml. Fourteen days after the administration of a booster dose, the antibody levels ranged from 10 to ≥ 100 IU/ml for all except one vaccinee (5·2 IU/ml). These findings demonstrate that the majority of vaccinees retained detectable neutralizing antibody after pre-exposure prophylaxis for as long as 5 years and that a single booster dose thereafter evoked a good antibody response.

Type
Research Article
Information
Epidemiology & Infection , Volume 99 , Issue 1 , August 1987 , pp. 91 - 95
Copyright
Copyright © Cambridge University Press 1987

References

REFERENCES

ACIP (1984). Recommendation of the Immunization Practices Advisory Committee on Rabies Prevention-United States, 1984. Centers for Disease Control Morbidity and Mortality Weekly Report 33, 393–408.Google Scholar
Aoki, F. Y., Tyrrell, D. A. J., Hill, L. E. & Turner, G. S. (1975). Tmmunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet i, 660–662.CrossRefGoogle Scholar
Bahmanyar, M., Fayaz, A., Nour-Salehi, S., Mohammadi, M. & Koprowski, H. (1976). Successful protection of humans exposed to rabies infection: postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. Journal of the American Medical Association 236, 2751–2754.CrossRefGoogle ScholarPubMed
Fayaz, A., Simani, S., Nour-Salehi, S. & Bahmanyar, M. (1981). Booster effect of human diploid cell antirabies vaccine in previously treated persons. Journal of the American Medical Association 246, 2334–2335.CrossRefGoogle ScholarPubMed
Nicholson, K. G., Turner, G. S. & Aoki, F. Y. (1978). Immunization with a human diploid cell strain of rabies virus vaccine: two-year results. Journal of Infectious Diseases 137, 783–788.CrossRefGoogle ScholarPubMed
Plotkin, S. A. (1980). Rabies vaccine prepared in human cell cultures: progress and perspectives. Reviews of Infectious Diseases 2, 433–448.CrossRefGoogle Scholar
Roumiantzeff, M., Aijan, N., Branche, R., Fournier, P., Montagnon, B., Trotemann, P., & Vincent-Falquet, J. C. (1984). Rabies vaccine produced in cell culture: production control and clinical results. In Applied Virology (ed. Kurstak, E., Al-Nakib, W. and Kurstak, C.), pp. 241–296. London: Academic Press Inc.CrossRefGoogle Scholar
Smith, J. S., Yager, P. A. & Baer, G. M. (1973). A rapid reproducible test for determining rabies neutralizing antibody. Bulletin of the World Health Organization 48, 535–541.Google ScholarPubMed